Medicare pays for kidney disease teaching starting 2027
H.R. 9509 — Kidney Disease Education Access Expansion Act of 2026 · Filed by Suzan DelBene (D-WA) · 4 cosponsors · Introduced Jun 29, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
Starting January 2027, Medicare and private plans will pay for kidney disease teaching. Doctors, nurses, and health workers can teach patients. They teach people with kidney disease, diabetes, or high blood pressure. Teaching can happen one-on-one, in groups, by video call, or with family members there. Medicare pays 100% of the cost. The government must set up a group to measure how well it works. This group has two years to finish.
Who it affects
People with kidney disease, diabetes, or high blood pressure get free teaching. They can use Medicare or private plans. Family members can attend. Rural and underserved patients can use video calls.
One thing to notice
The government decides how many teaching sessions patients can have. The government also decides what tests to use. The government has two years to measure if it works. It may use those results to change what it pays for.
From the analysis of the bill text, linked under Primary records below.
Where it stands
4 cosponsors: 2 Democrats, 2 Republicans.
- Jun 29, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jun 29, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
4 groups reported lobbying about this bill. They filed 4 reports from Jun 2026 to Jun 2026.
Those reports show $310,000 in lobbying spending. Each report lists about 9 bills. So that money was not all for this bill.
More groups named this bill than 72% of bills with any report.
Suzan DelBene, who sponsored the bill, received $1,589,799 from PACs for the 2026 election.
- Travere Therapeutics — $140,000 in 1 report
- National Kidney Foundation — $80,000 in 1 report
- American Society of Nephrology — $60,000 in 1 report
- National Kidney Foundation — $30,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- Medicare — Health insurance run by the government for people 65 and older and some younger people
- video call — Medical care given by phone or computer screen instead of in person
- private plans — Health insurance sold by companies, not run by the government
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
- sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 5, 2026; transparency and hidden-provision scores are compared against the median of 14,707 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-09-23.
“Medicare pays for kidney disease teaching starting 2027” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9509/simple Report an error